Narcolepsy
0.100
GeneticVariation
disease
GWASDB
Genome-wide association database developed in the Japanese Integrated Database Project.
19629137
2009
Transitional cell carcinoma of bladder
0.300
GeneticVariation
disease
UNIPROT
Bipolar Disorder
0.320
Biomarker
disease
PSYGENET
The positional candidate approach showed an association between bipolar disorder and TRPM2 (21q22.3), GPR50 (Xq28), Citron (12q24), CHMP1.5 (18p11.2), GCHI (14q22-24), MLC1 (22q13), GABRA5 (15q11-q13), BCR (22q11), CUX2, FLJ32356 (12q23-q24), and NAPG (18p11).
17239033
2007
Bipolar Disorder
0.320
Biomarker
disease
PSYGENET
Various other protein products of genes associated with bipolar disorder either bind to or are affected by phosphatidyl-inositol phosphate products of this pathway (ADBRK2, HIP1R, KCNQ2, RGS4, WFS1), are associated with its constituent elements (BCR , DUSP6, FAT, GNAZ) or are downstream targets of this signalling cascade (DPYSL2, DRD3, GAD1, G6PD, GCH1, KCNQ2, NOS3, SLC6A3, SLC6A4, SST, TH, TIMELESS).
17239488
2007
Bipolar Disorder
0.320
Biomarker
disease
PSYGENET
We previously reported a significant association between genetic variations in the breakpoint cluster region (BCR ) gene and bipolar disorder .
17822820
2008
Bipolar Disorder
0.320
Biomarker
disease
PSYGENET
Our results suggest that genetic variations in the BCR gene could confer susceptibility to bipolar disorder and major depressive disorder.
15866548
2005
Unipolar Depression
0.310
Biomarker
disease
PSYGENET
Our results suggest that genetic variations in the BCR gene could confer susceptibility to bipolar disorder and major depressive disorder .
15866548
2005
Major Depressive Disorder
0.310
Biomarker
disease
PSYGENET
Our results suggest that genetic variations in the BCR gene could confer susceptibility to bipolar disorder and major depressive disorder .
15866548
2005
Myeloid Leukemia, Chronic
0.700
FusionGene
disease
ORPHANET
Precursor B-cell lymphoblastic leukemia
0.400
FusionGene
disease
ORPHANET
A diagnosis of BCR -ABL1 (p190)-positive and ETV6-RUNX1-positive B-ALL was made, and treatment was initiated according to the AIEOP-BFM-ALL2000 protocol.
23491079
2013
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
0.380
FusionGene
disease
ORPHANET
Burkitt Lymphoma
0.340
FusionGene
disease
ORPHANET
Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
23491079
2013
Chromosome 22q11.2 Deletion Syndrome, Distal
0.300
ChromosomalRearrangement
disease
ORPHANET
Myeloid Leukemia, Chronic
0.700
Biomarker
disease
HPO
Myeloproliferative disease
0.500
Biomarker
group
HPO
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.500
Biomarker
disease
HPO
Neoplasms
0.200
Biomarker
group
HPO
B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
0.200
Biomarker
disease
HPO
Leukocytosis
0.130
Biomarker
phenotype
HPO
Thrombocytosis
0.130
Biomarker
disease
HPO
Fatigue
0.110
Biomarker
phenotype
HPO
×
CUI:
C0015967
Disease:
Fever
Fever
0.110
Biomarker
phenotype
HPO
Immunologic Deficiency Syndromes
0.110
Biomarker
group
HPO
Thrombocytopenia
0.110
Biomarker
phenotype
HPO
Aortic Aneurysm
0.100
Biomarker
disease
HPO